Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc (TSHA) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	5.36% 3.411	3.604	4.746	2.395	4.706
Operating Expenses	39.75% 27.74	19.85	21.00	25.78	21.27
Interest Income/Expense	95.93% 0.029	0.713	1.471	1.44	1.374
Benefits Costs and Expenses	162.24% 27.47	-44.14	-	-	22.33
Costs And Expenses	162.24% 27.47	-44.14	21.00	25.78	22.33
Operating Income/Loss	49.76% -24.33	-16.25	-16.25	-23.38	-16.56
Nonoperating Income/Loss	99.58% 0.269	63.99	-100.84	-1.214	-1.063
Income/Loss From Continuing Operations Before Tax	150.40% -24.06	47.74	4.746	2.395	-17.62
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	150.40% -24.06	47.74	-117.09	-24.60	-17.62
Net Income/Loss	150.40% -24.06	47.74	-117.09	-24.60	-17.62
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	634.34% 231.25	31.49	125.70	64.24	63.26
Diluted Average Shares	634.34% 231.25	31.49	125.70	64.24	63.26
Basic Earnings Per Share	110.87% -0.10	0.92	-0.93	-0.38	-0.28
Diluted Earnings Per Share	110.87% -0.10	0.92	-0.93	-0.38	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-